Osaka International Cancer Institute

Chuo-ku, Osaka 541-8567

1 studies enrolling now · 3 studies all time

What they study most

Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC), Glioblastoma, Leiomyosarcoma, Liposarcoma, Retroperitoneal Sarcoma

Studies at this site

• Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma — Recruiting now
• TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations — Running, not enrolling
• A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy — Completed